Bank of Montreal
SLN

Bank of Montreal’s Silence Therapeutics SLN Stock Holding History

Bank of Montreal’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Sell
201,734
-1,167
-0.6% -$8.21K ﹤0.01% 1694
2026
Q1 		$1.07M Buy
202,901
+42,427
+26% +$234K ﹤0.01% 2005
2025
Q4 		$976K Buy
160,474
+6,692
+4% +$42.8K ﹤0.01% 1994
2025
Q3 		$798K Buy
153,782
+7,970
+5% +$44.3K ﹤0.01% 2061
2025
Q2 		$846K Sell
145,812
-12,781
-8% -$54.8K ﹤0.01% 1988
2025
Q1 		$447K Buy
158,593
+93,586
+144% +$457K ﹤0.01% 2270
2024
Q4 		$447K Sell
65,007
-252
-0.4% -$3.25K ﹤0.01% 2295
2024
Q3 		$1.19M Buy
+65,259
New +$1.21M ﹤0.01% 1943

Other funds holding SLN

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Bank of Montreal's SLN Position: Q2 2026 in Review

Bank of Montreal reduced its Silence Therapeutics (SLN) stake by 0.58% in Q2 2026, selling an estimated $8.21K and leaving 201,734 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

Bank of Montreal first reported a position in SLN in Q3 2024 and has held it in 8 quarters since. 72 funds tracked by Wall St. Rank hold SLN as of Q2 2026.

  • Bank of Montreal held 201,734 shares of Silence Therapeutics worth $2.22M as of Q2 2026.
  • Bank of Montreal sold 1,167 Silence Therapeutics shares in Q2 2026, an estimated $8.21K.
  • Silence Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1694 holding.
  • Bank of Montreal first reported a position in Silence Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 72 funds tracked by Wall St. Rank held Silence Therapeutics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.